300896 Stock Overview
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 300896 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Imeik Technology Development Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥173.04 |
| 52 Week High | CN¥282.72 |
| 52 Week Low | CN¥132.81 |
| Beta | 1.4 |
| 1 Month Change | -15.66% |
| 3 Month Change | -21.32% |
| 1 Year Change | -20.57% |
| 3 Year Change | -48.81% |
| 5 Year Change | n/a |
| Change since IPO | 28.22% |
Recent News & Updates
Why Investors Shouldn't Be Surprised By Imeik Technology Development Co.,Ltd.'s (SZSE:300896) 25% Share Price Plunge
Jan 12
A Look At The Intrinsic Value Of Imeik Technology Development Co.,Ltd. (SZSE:300896)
Dec 24Analyst Forecasts Just Became More Bearish On Imeik Technology Development Co.,Ltd. (SZSE:300896)
Nov 06Imeik Technology Development Co.,Ltd. (SZSE:300896) Just Missed Earnings: Here's What Analysts Think Will Happen Next
Oct 26Recent updates
Why Investors Shouldn't Be Surprised By Imeik Technology Development Co.,Ltd.'s (SZSE:300896) 25% Share Price Plunge
Jan 12A Look At The Intrinsic Value Of Imeik Technology Development Co.,Ltd. (SZSE:300896)
Dec 24Analyst Forecasts Just Became More Bearish On Imeik Technology Development Co.,Ltd. (SZSE:300896)
Nov 06Imeik Technology Development Co.,Ltd. (SZSE:300896) Just Missed Earnings: Here's What Analysts Think Will Happen Next
Oct 26Investors Appear Satisfied With Imeik Technology Development Co.,Ltd.'s (SZSE:300896) Prospects As Shares Rocket 43%
Sep 27Are Investors Undervaluing Imeik Technology Development Co.,Ltd. (SZSE:300896) By 47%?
Jul 02Why Investors Shouldn't Be Surprised By Imeik Technology Development Co.,Ltd.'s (SZSE:300896) P/E
Feb 29Shareholder Returns
| 300896 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 2.2% | 3.1% | 3.5% |
| 1Y | -20.6% | -17.3% | 10.9% |
Return vs Industry: 300896 underperformed the CN Biotechs industry which returned -17.3% over the past year.
Return vs Market: 300896 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 300896 volatility | |
|---|---|
| 300896 Average Weekly Movement | 5.9% |
| Biotechs Industry Average Movement | 5.7% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in CN Market | 11.0% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 300896 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300896's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 910 | Yifeng Shi | www.imeik.net/cn/ |
Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel.
Imeik Technology Development Co.,Ltd. Fundamentals Summary
| 300896 fundamental statistics | |
|---|---|
| Market cap | CN¥52.16b |
| Earnings (TTM) | CN¥2.03b |
| Revenue (TTM) | CN¥3.07b |
25.7x
P/E Ratio17.0x
P/S RatioIs 300896 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300896 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.07b |
| Cost of Revenue | CN¥162.21m |
| Gross Profit | CN¥2.91b |
| Other Expenses | CN¥886.73m |
| Earnings | CN¥2.03b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 20, 2025
| Earnings per share (EPS) | 6.72 |
| Gross Margin | 94.72% |
| Net Profit Margin | 65.88% |
| Debt/Equity Ratio | 0% |
How did 300896 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 02:18 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Imeik Technology Development Co.,Ltd. is covered by 32 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ethan Cui | BofA Global Research |
| Jian Jun Zou | Chasing Securities |
| Xiyue Zhang | Chasing Securities |